| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aa2d1d961c591358634835e5743acd06 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-172 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6896
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate |
2004-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5586c6abb9d640cc2aa9ecae1fa84aa8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_21b1f3caba5f3b724c28a505e3dacdb4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9bdfaaac30f77df72d9e39e179e28806
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1667ffd366ab3589cca79fa6dcd3c895
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_646b2401966c9a46eab275497cc3440d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_36b90d6bcf2f58f44f05cf00b00259d6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_68062e1c86bd563c8a331e26b1b60255
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dfb5a488bc2d5b5e072f6feec8cdb3cc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f023620ef1a099f65d3fe90fb0e9a5f4 |
| publicationDate |
2005-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2005255488-A1 |
| titleOfInvention |
NTRK1 genetic markers associated with age of onset of Alzheimer's Disease |
| abstract |
Haplotypes in the NTRK1 gene associated with age of onset of Alzheimer's Disease are disclosed. Compositions and methods for detecting and using these NTRK1 haplotypes in a variety of clinical applications are disclosed. Such applications include articles of manufacture comprising compounds effective in delaying the age of onset of AD in individuals at risk for developing AD and having one of these NTRK1 haplotypes, methods and kits for predicting the age of onset of AD in an individual at risk for developing AD based upon his/her haplotype profile, and methods for delaying the age of onset of AD in individuals at risk for developing AD based upon their haplotype profile. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006154265-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008044809-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005277129-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006166219-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005255498-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005255495-A1 |
| priorityDate |
2003-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |